Theriva Biologics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Theriva Biologics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Theriva Biologics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $161K, a 58.5% decline year-over-year.
  • Theriva Biologics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $867K, a 40.2% decline year-over-year.
  • Theriva Biologics, Inc. annual Nonoperating Income (Expense) for 2023 was $1.44M, a 206% increase from 2022.
  • Theriva Biologics, Inc. annual Nonoperating Income (Expense) for 2022 was $471K, a 7750% increase from 2021.
  • Theriva Biologics, Inc. annual Nonoperating Income (Expense) for 2021 was $6K, a 86.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $867K $161K -$227K -58.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.09M $172K -$205K -54.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.3M $227K -$143K -38.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.44M $307K -$7K -2.23% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $1.45M $388K +$227K +141% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.22M $377K +$360K +2118% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $862K $370K +$391K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $471K $314K +$312K +15600% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $159K $161K +$159K +7950% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $0 $17K +$15K +750% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$15K -$21K -$21K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $6K $2K +$2K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $4K $2K +$2K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2K $2K -$4K -66.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $6K $0 -$38K -100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $44K $0 -$67K -100% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $111K $0 -$92K -100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $203K $6K -$74K -92.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $277K $38K -$6K -13.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $283K $67K +$1K +1.52% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $282K $92K -$539K -85.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $821K $80K -$709K -89.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.53M $44K -$2.62M -98.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $4.15M $66K -$8.53M -99.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 $12.7M $631K +$5.72M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 $6.96M $789K -$1.37M -63.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $8.33M $2.66M -$2.43M -47.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $10.8M $8.6M +$864K +11.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $9.9M -$5.09M -$5.76M -863% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $15.7M $2.16M -$1.39M -39.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $17M $5.09M +$5.59M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $11.4M $7.73M +$7.64M +7954% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-22
Q3 2016 $3.81M $667K -$3.48M -83.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $7.29M $3.55M +$7.44M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$151K -$497K +$3.65M +88% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$3.81M $96K -$525K -84.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-22
Q3 2015 -$3.28M $4.14M +$4.14M +414200% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 -$7.42M -$3.89M -$3.99M -4198% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$3.43M -$4.15M -$4.15M -415200% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $718K $621K +$573K +1194% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 $145K $1K +$4K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $141K $95K +$131K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $10K $1K -$11K -91.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $21K $48K +$55K Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 -$34K -$3K -$13K -130% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$21K -$36K -$43K -614% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $22K $12K +$7K +140% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $15K -$7K +$12K +63.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $3K $10K +$169K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$166K $7K +$768K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$934K $5K +$764K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$1.7M -$19K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-16
Q3 2011 -$159K -$159K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$761K -$767K -11809% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-11
Q1 2011 -$759K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 $293* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $6.5K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.